Literature DB >> 24680430

Tuning up the right signal: chemical and genetic approaches to study GPCR functions.

Patrick M Giguere1, Wesley K Kroeze2, Bryan L Roth3.   

Abstract

The G protein-coupled receptor (GPCR) family is among the most druggable families in the human proteome. GPCRs are involved in most physiological processes, and our ability to modulate their activity is a hallmark of modern pharmacology. The means by which the activity of GPCRs can be modulated have been expanded by emerging data and concepts in pharmacology, which has created new strategies for their control. These new approaches will lead to the generation of more potent, selective, and efficient pharmaceutics, while reducing inappropriate actions and adverse effects. Herein, we review and comment on some recent advances in chemical and genetic approaches to the profiling of GPCR function, as well as the validation of orphan GPCRs as potential therapeutic targets using engineered receptors.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24680430      PMCID: PMC3971376          DOI: 10.1016/j.ceb.2013.11.006

Source DB:  PubMed          Journal:  Curr Opin Cell Biol        ISSN: 0955-0674            Impact factor:   8.382


  28 in total

1.  Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists.

Authors:  Beili Wu; Ellen Y T Chien; Clifford D Mol; Gustavo Fenalti; Wei Liu; Vsevolod Katritch; Ruben Abagyan; Alexei Brooun; Peter Wells; F Christopher Bi; Damon J Hamel; Peter Kuhn; Tracy M Handel; Vadim Cherezov; Raymond C Stevens
Journal:  Science       Date:  2010-10-07       Impact factor: 47.728

2.  Evolution of key cell signaling and adhesion protein families predates animal origins.

Authors:  Nicole King; Christopher T Hittinger; Sean B Carroll
Journal:  Science       Date:  2003-07-18       Impact factor: 47.728

Review 3.  The evolving role of lipid rafts and caveolae in G protein-coupled receptor signaling: implications for molecular pharmacology.

Authors:  Rennolds S Ostrom; Paul A Insel
Journal:  Br J Pharmacol       Date:  2004-08-02       Impact factor: 8.739

Review 4.  New insights from structural biology into the druggability of G protein-coupled receptors.

Authors:  Jonathan S Mason; Andrea Bortolato; Miles Congreve; Fiona H Marshall
Journal:  Trends Pharmacol Sci       Date:  2012-03-30       Impact factor: 14.819

Review 5.  Functional selectivity and classical concepts of quantitative pharmacology.

Authors:  Jonathan D Urban; William P Clarke; Mark von Zastrow; David E Nichols; Brian Kobilka; Harel Weinstein; Jonathan A Javitch; Bryan L Roth; Arthur Christopoulos; Patrick M Sexton; Keith J Miller; Michael Spedding; Richard B Mailman
Journal:  J Pharmacol Exp Ther       Date:  2006-06-27       Impact factor: 4.030

Review 6.  How many drug targets are there?

Authors:  John P Overington; Bissan Al-Lazikani; Andrew L Hopkins
Journal:  Nat Rev Drug Discov       Date:  2006-12       Impact factor: 84.694

7.  Allele-specific activation of genetically engineered receptors.

Authors:  C D Strader; T Gaffney; E E Sugg; M R Candelore; R Keys; A A Patchett; R A Dixon
Journal:  J Biol Chem       Date:  1991-01-05       Impact factor: 5.157

8.  Evolving the lock to fit the key to create a family of G protein-coupled receptors potently activated by an inert ligand.

Authors:  Blaine N Armbruster; Xiang Li; Mark H Pausch; Stefan Herlitze; Bryan L Roth
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-02       Impact factor: 11.205

9.  Generation of designer receptors exclusively activated by designer drugs (DREADDs) using directed molecular evolution.

Authors:  Ying Pei; Shuyun Dong; Bryan L Roth
Journal:  Curr Protoc Neurosci       Date:  2010-01

10.  Automated design of ligands to polypharmacological profiles.

Authors:  Jérémy Besnard; Gian Filippo Ruda; Vincent Setola; Keren Abecassis; Ramona M Rodriguiz; Xi-Ping Huang; Suzanne Norval; Maria F Sassano; Antony I Shin; Lauren A Webster; Frederick R C Simeons; Laste Stojanovski; Annik Prat; Nabil G Seidah; Daniel B Constam; G Richard Bickerton; Kevin D Read; William C Wetsel; Ian H Gilbert; Bryan L Roth; Andrew L Hopkins
Journal:  Nature       Date:  2012-12-13       Impact factor: 49.962

View more
  10 in total

Review 1.  Peptidomics for the discovery and characterization of neuropeptides and hormones.

Authors:  Elena V Romanova; Jonathan V Sweedler
Journal:  Trends Pharmacol Sci       Date:  2015-07-01       Impact factor: 14.819

Review 2.  The delivery of therapeutic oligonucleotides.

Authors:  Rudolph L Juliano
Journal:  Nucleic Acids Res       Date:  2016-04-15       Impact factor: 16.971

3.  Novobiocin and peptide analogs of α-factor are positive allosteric modulators of the yeast G protein-coupled receptor Ste2p.

Authors:  Jeffrey K Rymer; Melinda Hauser; Allen K Bourdon; Shawn R Campagna; Fred Naider; Jeffrey M Becker
Journal:  Biochim Biophys Acta       Date:  2015-01-07

Review 4.  New paradigms in GPCR drug discovery.

Authors:  Kenneth A Jacobson
Journal:  Biochem Pharmacol       Date:  2015-08-08       Impact factor: 5.858

5.  What can we learn from molecular dynamics simulations for GPCR drug design?

Authors:  Christofer S Tautermann; Daniel Seeliger; Jan M Kriegl
Journal:  Comput Struct Biotechnol J       Date:  2014-12-10       Impact factor: 7.271

6.  The first structure-activity relationship studies for designer receptors exclusively activated by designer drugs.

Authors:  Xin Chen; Hyunah Choo; Xi-Ping Huang; Xiaobao Yang; Orrin Stone; Bryan L Roth; Jian Jin
Journal:  ACS Chem Neurosci       Date:  2015-01-27       Impact factor: 4.418

Review 7.  Fluorescent knock-in mice to decipher the physiopathological role of G protein-coupled receptors.

Authors:  Rhian A Ceredig; Dominique Massotte
Journal:  Front Pharmacol       Date:  2015-01-06       Impact factor: 5.810

8.  Gs-DREADD Knock-In Mice for Tissue-Specific, Temporal Stimulation of Cyclic AMP Signaling.

Authors:  Dmitry Akhmedov; Maria G Mendoza-Rodriguez; Kavitha Rajendran; Mario Rossi; Jürgen Wess; Rebecca Berdeaux
Journal:  Mol Cell Biol       Date:  2017-04-14       Impact factor: 4.272

Review 9.  State-of-the-Art Techniques to Causally Link Neural Plasticity to Functional Recovery in Experimental Stroke Research.

Authors:  Anna-Sophia Wahl
Journal:  Neural Plast       Date:  2018-05-27       Impact factor: 3.599

10.  Orphan GPR110 (ADGRF1) targeted by N-docosahexaenoylethanolamine in development of neurons and cognitive function.

Authors:  Ji-Won Lee; Bill X Huang; HeungSun Kwon; Md Abdur Rashid; Giorgi Kharebava; Abhishek Desai; Samarjit Patnaik; Juan Marugan; Hee-Yong Kim
Journal:  Nat Commun       Date:  2016-10-19       Impact factor: 14.919

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.